Rhode Island HB 5913: AN ACT RELATING TO BUSINESSES AND PROFESSIONS - PHARMACEUTICAL COST TRANSPARENCY (Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.)

Status: 03/23/2021 Committee recommended measure be held for further study (as of 2021-03-23)

State: Rhode Island · Session: 2021 · Bill: HB 5913

Subjects: Business & Professions, Fees, Food and Drugs, Prescription drugs

Sponsors: J Lombardi

View Rhode Island HB 5913 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.